Jefferies Sees Much Larger Market Opportunity For AstraZeneca, Upgrades To Buy

By: via Benzinga
Jefferies’ Jeffrey Holford believes there is a much higher probability of AstraZeneca plc (ADR) (NYSE: AZN) achieving success with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.